
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and …
Ventilator-associated pneumonia is defined as pneumonia occurring more than 48 h after patients have been intubated and received mechanical ventilation. Diagnosing VAP requires a high clinical suspicion combined with bedside examination, radiographic examination, and microbiologic analysis of respiratory secretions.
Ventilator-associated pneumonia in adults: a narrative review
Ventilator-associated pneumonia (VAP) is defined by infection of the pulmonary parenchyma in patients exposed to invasive mechanical ventilation for at least 48 h and is part of ICU-acquired pneumonia. VAP remains one of the most common infections in patients requiring invasive mechanical ventilation.
Treatment of hospital-acquired and ventilator-associated ... - UpToDate
The treatment of non-ventilator-associated HAP (nvHAP) and ventilator-associated pneumonia (VAP) will be reviewed here. The diagnosis, epidemiology, pathogenesis, microbiology, risk factors, and prevention of nvHAP and VAP are discussed separately.
Hospital-acquired and Ventilator-associated Pneumonia (HAP/VAP)
These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare ...
Preventing ventilator-associated pneumonia: A position paper of …
2025年2月1日 · The recommendations and insights provided in this position paper aim to guide healthcare professionals in effectively preventing VAP. The adoption of evidence-based preventive strategies can potentially reduce VAP rates, and associated costs, and improve patient outcomes in both high-income and LMICs.
Hospital-acquired and ventilator-associated pneumonia: …
2020年10月1日 · Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) cause significant inpatient morbidity and mortality. They are especially challenging to diagnose promptly in the intensive care unit because a plethora of other causes can contribute to clinical decline in complex, critically ill patients.
These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare provider...
Prophylactic antibiotics for preventing ventilator-associated …
2023年9月15日 · The role of prophylactic antibiotics in preventing ventilator-associated pneumonia (VAP) in patients undergoing invasive mechanical ventilation (IMV) remains unclear. This network meta-analysis compared the efficacy and safety of antibiotic prophylaxis in preventing VAP in an IMV population in intensive-care units (ICUs).
Ventilator Associated Pneumonia (VAP) - EMCrit Project
2024年8月25日 · There are roughly four sources of clinical information that should be rapidly available when considering the possibility of VAP. Try to consider all evidence rather than anchoring on a single bit of evidence. Sensitivity ~64%, specificity ~59%. Left-shift, neutrophil/lymphocyte ratio. Sensitivity 66%; specificity 54%. Hypothermia. Septic shock.
American Journal of Respiratory and Critical Care Medicine
The 2016 HAP/VAP guidelines focus on the need to monitor local bacterial resistance via antibiograms, preferably ones specific to certain areas of the hospital, such as the intensive care unit.